Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion type Assertion NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_head.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion description "[CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion evidence source_evidence_literature NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion SIO_000772 26175413 NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion wasDerivedFrom befree-2016 NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.
- NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_assertion wasGeneratedBy ECO_0000203 NP1290146.RA71iJY8Eqks2ItqOVZK9IZlXet9DjRnMvpojx_OCAb1s130_provenance.